Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cycloleucine 是 NMDA 受体相关甘氨酸受体的拮抗剂,Ki 为 600 μM。Cycloleucine 也是 S-腺苷甲硫氨酸介导的甲基化的竞争性抑制剂,具有抗焦虑和细胞抑制作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
10 mg | ¥ 216 | 现货 | ||
25 mg | ¥ 413 | 现货 | ||
50 mg | ¥ 588 | 现货 | ||
100 mg | ¥ 882 | 现货 | ||
200 mg | ¥ 1,280 | 现货 | ||
500 mg | ¥ 2,180 | 现货 |
产品描述 | Cycloleucine is an antagonist of NMDA receptor associated glycine receptor with a Ki of 600 μM. Cycloleucine is also a competitive inhibitor of S-adenosyl-methionine mediated methylation with anxiolytic and cytostatic effects. |
体外活性 | Cytostatic (10 µg/mL) inhibits the viability of human KB and mouse L1210s leukemia cell lines. Cycloleucine (4-40 mM; 3 h) blocks internal methylation of viral RNA in B77 transformed chick embryo fibroblasts. Cycloleucine (40 mM; 24 h) blocks the formation of both m6A and the penultimate Gm in B77 38S RNA subunits by greater than 90%[2]. |
体内活性 | Cycloleucine (0.5, 1.0, 2.0, 4 µg/µL; intracerebroventrically) increases time spent in open arms, open arm entries, and extreme arrivals in rats[3]. In Semliki Forest virus strain A7(74) infected and control mice, Cycloleucine reduces thymus and spleen weights[4]. |
分子量 | 129.16 |
分子式 | C6H11NO2 |
CAS No. | 52-52-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 45 mg/mL (348.41 mM), Sonication is recommended.
DMSO: < 1 mg/mL (insoluble or slightly soluble), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O | 1 mM | 7.7423 mL | 38.7117 mL | 77.4234 mL | 193.5584 mL |
5 mM | 1.5485 mL | 7.7423 mL | 15.4847 mL | 38.7117 mL | |
10 mM | 0.7742 mL | 3.8712 mL | 7.7423 mL | 19.3558 mL | |
20 mM | 0.3871 mL | 1.9356 mL | 3.8712 mL | 9.6779 mL | |
50 mM | 0.1548 mL | 0.7742 mL | 1.5485 mL | 3.8712 mL | |
100 mM | 0.0774 mL | 0.3871 mL | 0.7742 mL | 1.9356 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Cycloleucine 52-52-8 Neuroscience NMDAR Ionotropic glutamate receptors inhibit glycine NMDA cytostatic nucleic Inhibitor methylations anxiolytic transferase iGluR ATP inhibitor